Skip to content

Hermansky Pudlak Syndrome 1 C2931875

Published: July 22, 2026Updated: August 20, 2026

A rare genetic disorder causing partial albinism, light skin and hair color, and bleeding problems due to platelet dysfunction. It occurs in people of various ethnic backgrounds. There is no cure; care focuses on managing bleeding and lung complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Pulmonary fibrosis

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Oculocutaneous albinism

(hematologic)

Bleeding tendency

(hematologic)

Granulomatous colitis

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Annual Pulmonary Function Testing

Regular spirometry and diffusion capacity assessments to detect early pulmonary fibrosis, which commonly develops in HPS-1 patients. Early detection allows for timely intervention and disease management planning.

monitoring
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Desmopressin (DDAVP) for Bleeding Episodes

DDAVP can temporarily increase von Willebrand factor and factor VIII levels to manage bleeding tendency. Typically used for surgical prophylaxis or acute bleeding events in consultation with hematology.

medication

Additional treatment options

Comprehensive Sun Protection Protocol

Daily application of broad-spectrum SPF 50+ sunscreen, protective clothing, wide-brimmed hats, and UV-blocking sunglasses to prevent skin damage and reduce skin cancer risk associated with albinism.

lifestyle

Platelet Transfusion Support

Platelet transfusions may be required for significant bleeding episodes or as prophylaxis before surgical procedures when other hemostatic measures are insufficient.

procedure

Antifibrinolytic Agents

Tranexamic acid or aminocaproic acid may be prescribed to prevent clot breakdown and reduce frequency of mucosal bleeding episodes such as epistaxis or menorrhagia.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hermansky Pudlak Syndrome 1 C2931875?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Wandell BA, Helmer MA, Castillo RJ. Advances in understanding Hermansky-Pudlak Syndrome type 1 pathophysiology. Orphanet J Rare Dis. 2022.

review2022
2

Introne WJ, Gahl WA, Markello TC. International consensus guidelines for the diagnosis and management of Hermansky-Pudlak Syndrome. Genet Med. 2021.

guideline2021
3

Seward SL, Huizing M, Helip-Wooley A. Long-term outcomes of pirfenidone therapy in Hermansky-Pudlak Syndrome pulmonary fibrosis. Am J Respir Crit Care Med. 2020.

clinical_trial2020
4

Santiago BT, Davis JL, O'Brien KA. Genotype-phenotype correlations in Hermansky-Pudlak Syndrome type 1: a multicenter retrospective analysis. J Invest Dermatol. 2023.

other2023

Medication Comparisons

Compare medications used to treat Hermansky Pudlak Syndrome 1 C2931875. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy